# ACTiF- Assessment of Closed Tibial Fractures

> **NCT00533377** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 276 (actual)

## Conditions studied

- Tibial Fractures

## Interventions

- **DRUG:** CP-533, 536
- **DRUG:** Placebo
- **PROCEDURE:** Standard of Care
- **DRUG:** CP-533,536
- **DRUG:** CP-533,536
- **DRUG:** CP-533,536

## Key facts

- **NCT ID:** NCT00533377
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2012-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00533377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00533377, "ACTiF- Assessment of Closed Tibial Fractures". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00533377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*